|
ZBTB26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.933890E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.595000E-01 |
| Normal-vs-Stage2 |
5.199000E-01 |
| Normal-vs-Stage3 |
9.75800000000415E-05 |
| Normal-vs-Stage4 |
6.28449999999781E-05 |
| Stage1-vs-Stage2 |
6.451200E-01 |
| Stage1-vs-Stage3 |
1.65345999999511E-05 |
| Stage1-vs-Stage4 |
1.78795999999926E-05 |
| Stage2-vs-Stage3 |
2.910000E-02 |
| Stage2-vs-Stage4 |
1.061830E-02 |
| Stage3-vs-Stage4 |
5.619800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.741920E-02 |
| Normal-vs-AfricanAmerican |
1.626630E-01 |
| Normal-vs-Asian |
5.482200E-01 |
| Caucasian-vs-AfricanAmerican |
9.537200E-01 |
| Caucasian-vs-Asian |
2.140200E-01 |
| AfricanAmerican-vs-Asian |
3.000000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.241400E-03 |
| Normal-vs-Female |
3.028000E-01 |
| Male-vs-Female |
4.488100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.554000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.061000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.861600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.638600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.292600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.622000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.076200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.796400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.500400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.456600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.195900E-02 |
| Normal-vs-Grade 2 |
8.600600E-01 |
| Normal-vs-Grade 3 |
1.659990E-03 |
| Normal-vs-Grade 4 |
1.36939999995089E-06 |
| Grade 1-vs-Grade 2 |
9.659900E-02 |
| Grade 1-vs-Grade 3 |
1.144340E-03 |
| Grade 1-vs-Grade 4 |
7.75000000000636E-05 |
| Grade 2-vs-Grade 3 |
9.52440000000498E-05 |
| Grade 2-vs-Grade 4 |
1.25160000030711E-07 |
| Grade 3-vs-Grade 4 |
7.735600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.378200E-01 |
| Normal-vs-ccB subtype |
1.570870E-04 |
| ccA subtype-vs-ccB subtype |
1.43499989668783E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.389900E-02 |
| Normal-vs-N1 |
1.682850E-03 |
| N0-vs-N1 |
4.249700E-02 |
|
|
